NCT02040623 - Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Chronic Graft-versus-host Disease

Interventions

DRUG

R348 Ophthalmic Solution, 0.2%

R348 Ophthalmic Solution 0.2% 2 drops per eye twice a day

DRUG

R348 Ophthalmic Solution, 0.5%

R348 Ophthalmic Solution, 0.5% 2 drops per eye twice a day

OTHER

Placebo Ophthalmic Solution

Placebo Ophthalmic Solution 2 drops per eye twice a day

Trial Locations (2)

U. Miami - Bascom Palmer Eye Institute, Plantation

Massachusetts Eye and Ear Infirmary, Boston